ホームページ Immunology & Inflammation LAG-3

LAG-3

LAG-3製品

  • All (2)
  • LAG-3阻害剤 (1)
  • LAG-3抗体(1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
A2029 Relatlimab (anti-LAG-3) Relatlimab (BMS-986016, RELA) is a human LAG-3 specific monoclonal antibody that binds to LAG-3 on T cells, restoring effector function of exhausted T cells.
Mol Ther Nucleic Acids, 2024, 35(2):102225
Sci Rep, 2024, 14(1):31504
J Clin Invest, 2023, 133(9)e164528
A2029-Relatlimab-anti-LAG-3.gif
A2995 Fianlimab (Anti-LAG3 / CD223) Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.
A2029 Relatlimab (anti-LAG-3) Relatlimab (BMS-986016, RELA) is a human LAG-3 specific monoclonal antibody that binds to LAG-3 on T cells, restoring effector function of exhausted T cells.
Mol Ther Nucleic Acids, 2024, 35(2):102225
Sci Rep, 2024, 14(1):31504
J Clin Invest, 2023, 133(9)e164528
 A2029-Relatlimab-anti-LAG-3.gif
A2995 Fianlimab (Anti-LAG3 / CD223) Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.
united states